Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/2014
10/02/2014WO2014159937A1 Cyclic peptoid oligomers, pharmaceutical compositions and methods of using the same
10/02/2014WO2014159878A2 Intranasal administration of guanidinylated aminoglycosides
10/02/2014WO2014159745A1 Combinations of bruton's tyrosine kinase inhibitors and cyp3a4 inhibitors
10/02/2014WO2014159559A1 Fused furans for the treatment of hepatitis c
10/02/2014WO2014159076A1 Inhibitors of human immunodeficiency virus replication
10/02/2014WO2014158963A1 Antibodies targeted to fungal cell wall polysaccharides
10/02/2014WO2014158761A1 Aromatic carboxylic acids in combination with aromatic hydroxyamides for inactivating non-enveloped viruses
10/02/2014WO2014158123A1 Gene optimized hantaan virus m segment dna vaccine for hemorrhagic fever with renal syndrome
10/02/2014WO2014158045A1 Dimeric quaternary pyridinium salts possessing biocidal activity
10/02/2014WO2014157622A1 Antiviral agent against non-enveloped viruses and use thereof
10/02/2014WO2014157595A1 Novel polypeptides and utilization thereof
10/02/2014WO2014157380A1 Therapeutic agent for wounds or fibrosis
10/02/2014WO2014157174A1 Composition for body, and anti-fungal agent against malassezia
10/02/2014WO2014157107A1 Polypeptide having sialylated sugar chains attached thereto
10/02/2014WO2014155301A1 Substituted bicyclic compounds as inhibitors of ezh2
10/02/2014WO2014155097A1 Inhibitor for treatment of hcv infection
10/02/2014WO2014154921A1 Method for the synthesis of homologous compounds of azanucleosides
10/02/2014WO2014154899A1 Use of a macrocyclic lactone for treating a complication from a papillomavirus infection
10/02/2014WO2014154891A1 Cgrp receptor agonist for hiv treatment or prevention
10/02/2014WO2014154134A1 Polypeptide having inhibitory effect against infection by novel coronavirus hcov-emc 2012 and application of the polypeptide
10/02/2014WO2014153674A1 Influenza virus-like particle production in plants
10/02/2014WO2014153624A1 Antibacterial compounds
10/02/2014US20140296498 Tiacumicin Production
10/02/2014US20140294935 Vaccine composition
10/02/2014US20140294892 Construction of west nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by west nile virus
10/02/2014US20140294884 Meningococcus adhesins nada, app and orf 40
10/02/2014US20140294763 Peptidomimetic protease inhibitors
10/01/2014EP2784075A1 Hepatitis C virus inhibitors
10/01/2014EP2782922A1 Antibacterial tylosin derivatives and methods for their preparation
10/01/2014EP2782597A1 Nucleic acid vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
10/01/2014EP2782589A2 Anti-microbial peptides and methods of use thereof
09/2014
09/30/2014US8846893 Non-ionically bound constructs, and compositions and kits comprising domains
09/30/2014US8846696 Purine derivatives
09/30/2014US8846650 Method of treating middle ear infections
09/30/2014US8846609 Leukotoxin E/D as a new anti-inflammatory agent and microbicide
09/30/2014US8846607 Particles for treatment of pulmonary infection
09/30/2014US8846026 Composition comprising immunogenic microparticles
09/25/2014WO2014152635A1 Combination of direct acting antiviral agents and ribavirin for treating hcv patients
09/25/2014WO2014152514A1 Combination of two antivirals for treating hepatitis c
09/25/2014WO2014152444A1 Histone deacetylase inhibitors
09/25/2014WO2014152332A1 Methods of treating infections in overweight and obese patients using antibiotics
09/25/2014WO2014152275A1 Deuterium modified derivatives of the ns5b polymerase inhibitor tmc647055
09/25/2014WO2014152231A1 Methods and compositions for bacteriophage therapy
09/25/2014WO2014151837A1 A bacillus subtilis strain for use in maintaining or improving the paw health of poultry
09/25/2014WO2014151771A1 Compositions and methods for treating an immunodeficiency virus infection
09/25/2014WO2014151719A1 Sublingual formulations including geranylgeranylacetone and geranylgeranylacetone derivatives
09/25/2014WO2014151567A1 Oral care compositions containing deoxy sugar antimetabolites
09/25/2014WO2014151526A1 Biological therapeutics for infection-relating disorders or conditions
09/25/2014WO2014151258A1 Substituted pyridine derivatives useful as c-fms kinase inhibitors
09/25/2014WO2014151085A1 Beraprost isomer as agent for the treatment of viral infection
09/25/2014WO2014150094A1 Butyrogenic bacteria as probiotics to treat clostridium difficile
09/25/2014WO2014149526A1 Phenylephrine resinate particles
09/25/2014WO2014149525A1 Phenylephrine resinate particles and use thereof in pharmaceutical formulations
09/25/2014WO2014148949A1 Alkyl 2-{[(2r,3s,5r)-5-(4-amino-2-oxo-2н-pyrimidin-1-yl)-3-hydroxy- tetrahydro-furan-2-yl-methoxy]-phenoxy-phosphoryl-amino}-propionates, nucleoside inhibitors of hcv ns5b rna-polymerase, and methods for producing and use thereof
09/25/2014WO2014148638A1 Aptamer to il-17 and use thereof
09/25/2014WO2014148574A1 Inhibition of production of il-2
09/25/2014WO2014148438A1 Therapeutic agent for hepatitis c which comprises 4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)benzene derivative
09/25/2014WO2014148422A1 Licorice hydrolysis extraction composition
09/25/2014WO2014147581A1 Plant extracts of ptaeroxylon obliquum and compounds having antimicrobial and antihelminthic activity
09/25/2014WO2014147405A1 Combination comprising zidovudine and polymyxin
09/25/2014WO2014147287A1 Nanocrystalline cellulose (ncc) as an antiviral compound
09/25/2014WO2014147178A1 Hdac6 inhibitors and uses thereof
09/25/2014WO2014147095A1 Lipohillic oligonucleotide analogs
09/25/2014WO2014146603A1 Pasteurella multocida toxin recombinant protein and use thereof
09/25/2014WO2014146218A1 Usage of mycophenolate mofetil or salt thereof in preparing drug for resisting against influenza virus
09/25/2014US20140288266 Synthesis of Cyclosporin Analogs
09/25/2014US20140287028 Use of Chemotherapeutic Agents
09/24/2014EP2781525A2 Novel derivatives of hemin with antibacterial and antiviral activity
09/24/2014EP2781523A1 Lipophilic oligonucleotide analogs
09/24/2014EP2781519A1 Novel antiviral pyrrolopyridine derivative and a production method for same
09/24/2014EP2781517A1 Nitrogenated heterocyclic compound
09/24/2014EP2781510A1 HIV inhibiting 5,6-substituted pyrimidines
09/24/2014EP2781221A1 Medicine for treatment and/or improvement of sepsis
09/24/2014EP2780371A1 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for regulating the fluid balance in a patient having a chronic or acute disease
09/24/2014EP2780370A1 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for use in therapy of an acute disease or acute condition of a patient for stabilizing the circulation
09/24/2014EP2780369A1 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for prevention or reduction of organ dysfunction or organ failure in a patient having a chronic or acute disease or acute condition
09/24/2014EP2780366A2 Rsv g protein specific antibodies
09/24/2014EP2780365A1 Lactoferrin derived peptides for use as broad- spectrum inhibitors of influenza virus infection
09/24/2014EP2780361A1 Conjugates of gm-csf and il-7, compositions and methods related thereto
09/24/2014EP2780352A1 Mannosylated compounds useful for the prevention and the treatment of infectious diseases
09/24/2014EP2780351A1 Clostridium difficile lipoteichoic acid and uses thereof
09/24/2014EP2780350A2 Synthetic derivatives of mpl and uses thereof
09/24/2014EP2780038A1 Vaccine comprising a tlr-5 agonist as adjuvant for use in cutaneous immunisation
09/24/2014EP2780007A1 Apricitabine and pi combination therapy
09/23/2014US8841433 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
09/23/2014US8841420 Synthetic peptide constructs for the diagnosis and treatment of periodontis associated with Porphyromonas gingivalis
09/23/2014US8841310 Combinations of a pyrimidine containing NNRTI with RT inhibitors
09/23/2014US8841307 Method of using diketopiperazines and composition containing them
09/23/2014US8841278 Antiviral compounds
09/23/2014US8840934 Uses of ammonium chloride
09/23/2014US8840932 Antiseptic compositions and methods
09/23/2014CA2688142C A process for stereoselective synthesis of lamivudine
09/23/2014CA2672261C Methods for treating cystic fibrosis or pneumonia with bacterial infection via pulmonary administration of fosfomycin
09/23/2014CA2608977C Antifungal agents
09/23/2014CA2608153C Thiazole derivatives for use as p13k modulators
09/23/2014CA2602121C Pharmaceutical composition and method using an antifungal arylamidine in combination
09/23/2014CA2548990C Toll-like receptor 4 (tlr4)-neutralizing antibodies
09/23/2014CA2546926C Compositions for the treatment of afflictions of the oral cavity and upper respiratory tract
09/18/2014WO2014145600A1 Ach-0142684 sodium salt polymorphs, composition including the same, and method of manufacture thereof
09/18/2014WO2014145507A1 A process for making a 4-amino-4-oxobutanoyl peptide cyclic analogue, an inhibitor of viral replication, and intermediates thereof
1 ... 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 ... 1798